Paper300751
Purification and properties of human lymphocyte activating factor (LAF).
Blyden G and 1 other. J Immunol, 1977. Cited by 179 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Download JSON
Cite this record
ConductScience Library. Purification and properties of human lymphocyte activating factor (LAF). Papers, record 300751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/300751
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biological Products | Major topic |
| Lymphocyte Activation | Major topic |
| Animals | |
| Cell Adhesion | |
| Humans | |
| In Vitro Techniques | |
| Leukocytes | |
| Mercaptoethanol | |
| Molecular Weight | |
| T-Lymphocytes | |
| Thymidine |
Source PubMed
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 179 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 12,824,917 | Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. | Cancer Sci | 2003 | https://conductscience.org/library/papers/12824917 | PubMed |
| 8,406,789 | Antibody-mediated enhancement of Legionella pneumophila-induced interleukin 1 activity. | Infect Immun | 1993 | https://conductscience.org/library/papers/8406789 | PubMed |
| 7,119,116 | Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. | J Clin Invest | 1982 | https://conductscience.org/library/papers/7119116 | PubMed |
| 6,977,479 | Amplification of the polyclonal activation of human T cells. I. Null-cell products promote the polyclonal proliferation of T cells. | Immunology | 1982 | https://conductscience.org/library/papers/6977479 | PubMed |
| 6,969,402 | Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6969402 | PubMed |
| 6,965,303 | Regulation of Fc fragment-induced murine spleen cell proliferation. | J Exp Med | 1980 | https://conductscience.org/library/papers/6965303 | PubMed |
| 6,895,055 | Release of chondrocyte-stimulating factor by rabbit peritoneal macrophages. | Clin Exp Immunol | 1981 | https://conductscience.org/library/papers/6895055 | PubMed |
| 6,611,552 | Macrophage-derived growth factor for osteoblast-like cells and chondrocytes. | Proc Natl Acad Sci U S A | 1984 | https://conductscience.org/library/papers/6611552 | PubMed |
| 6,605,406 | T cell-replacing factor for glucocorticosteroid-induced immunoglobulin production. A unique steroid-dependent cytokine. | J Exp Med | 1983 | https://conductscience.org/library/papers/6605406 | PubMed |
| 6,500,626 | Production of a lymphocyte proliferation potentiating factor by purified polymorphonuclear leucocytes from mice and rabbits. | Immunology | 1984 | https://conductscience.org/library/papers/6500626 | PubMed |
| 6,334,697 | Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6334697 | PubMed |
| 6,332,170 | Purification and partial biochemical characterization of normal human interleukin 1. | J Exp Med | 1984 | https://conductscience.org/library/papers/6332170 | PubMed |
| 6,332,077 | Interleukin 1 production by peripheral blood mononuclear cells from leprosy patients. | Infect Immun | 1984 | https://conductscience.org/library/papers/6332077 | PubMed |
| 6,325,504 | Silica-stimulated monocytes release fibroblast proliferation factors identical to interleukin 1. A potential role for interleukin 1 in the pathogenesis of silicosis. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6325504 | PubMed |
| 6,283,028 | Histocompatibility antigens on astrocytoma cells. | J Neurol Neurosurg Psychiatry | 1982 | https://conductscience.org/library/papers/6283028 | PubMed |
| 6,193,236 | Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells. | J Exp Med | 1983 | https://conductscience.org/library/papers/6193236 | PubMed |
| 6,184,434 | Definition of conditions that enable antigen-specific activation of the majority of isolated trinitrophenol-binding B cells. | J Exp Med | 1982 | https://conductscience.org/library/papers/6184434 | PubMed |
| 3,874,022 | Interleukin-1 production by mononuclear cells from patients with scleroderma. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/3874022 | PubMed |
| 3,871,836 | Human interleukin 1. Purification to homogeneity. | J Exp Med | 1985 | https://conductscience.org/library/papers/3871836 | PubMed |
| 3,540,948 | Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells. | Proc Natl Acad Sci U S A | 1986 | https://conductscience.org/library/papers/3540948 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/300751
GET https://conductscience.org/api/papers/v1/300751/cited_by?page=2